Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
Dodaran, Masoud Solaymani, Banihashemi, Seyed Reza, Es-Haghi, Ali, Mehrabadi, Mohammad Hossein Fallah, Nofeli, Mojtaba, Mokarram, Ali Rezaei, Mokhberalsafa, Ladan, Sadeghi, Fariba, Ranjbar, Alireza, Ansarifar, Akram, Mohazzab, Arash, Setarehdan, Seyed Amin, Bagheri Amiri, Fahimeh, Mohseni, Vahideh, Hajimoradi, Monireh, Ghahremanzadeh, Neda, Razzaz, Seyed Hossein, Masoomi, Safdar, Taghdiri, Maryam, Bagheri, Mohsen, Lofti, Mohsen, Khorasani, Akbar, Ghader, Masoud, Safari, Shiva, Shahsavn, Masumeh, Kalantari, Saeed
Published in Vaccines (Basel) (01.02.2023)
Published in Vaccines (Basel) (01.02.2023)
Get full text
Journal Article